Vanguard Global Advisers »

Leap Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.2k 12k 0.80

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Leap Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Susquehanna International
Geode Capital Management
Vanguard Fiduciary Trust
Citadel Advisors
UBS Group
LPL Financial
State Street Corporation
Jane Street
Group One Trading
Texas Capital Bank Wealth Management Services
Key Client Fiduciary Advisors
Northern Trust

View all funds holding Leap Therapeutics